Switch Therapeutics, a biotechnology company pioneering a new way to use RNA science to treat disease, today announced its Scientific Advisory Board made up of Drs. Marc Abrams, David Bredt and James Treanor. The post Switch Therapeutics Announces Formation of Scientific Advisory Board appeared first on Switch Therapeutics .